Low systolic blood pressure for predicting all-cause mortality in patients hospitalised with heart failure: a systematic review and meta-analysis

被引：4
|
作者：
Zhang, Yang [1 ]
Wang, Changqian [1 ]
Zhang, Junfeng [1 ]
Zhang, Huili [1 ]
Yin, Zhaofang [1 ]
Chen, Yu [1 ]
Xie, Qian [2 ]
机构：
[1] Shanghai Ninth Peoples Hosp, Dept Cardiol, Shanghai, Peoples R China
[2] Shanghai Univ Finance & Econ, Sch Foreign Studies, 777 GuoDing Rd, Shanghai 200433, Peoples R China
来源：
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY | 2019年 / 26卷 / 04期
关键词：
REDUCED EJECTION FRACTION;
D O I：
10.1177/2047487318784092
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：439 / 443
页数：5
相关论文
共 47 条
  • [31] Effects of neurohormonal antagonists on blood pressure in patients with heart failure with reduced ejection fraction (HFrEF): a systematic review protocol
    Guggilla, Rama Krishna
    Sowa, Pawel Mateusz
    Jamiolkowski, Jacek
    Sinnadurai, Siamala
    Amin, Adnan
    Kaminski, Karol Adam
    SYSTEMATIC REVIEWS, 2020, 9 (01)
  • [32] Effects of neurohormonal antagonists on blood pressure in patients with heart failure with reduced ejection fraction (HFrEF): a systematic review protocol
    Rama Krishna Guggilla
    Pawel Mateusz Sowa
    Jacek Jamiolkowski
    Siamala Sinnadurai
    Adnan Amin
    Karol Adam Kaminski
    Systematic Reviews, 9
  • [33] Impact of exercise training on clinical outcomes and quality of life in chronic congestive heart failure: A systematic review and meta-analysis
    Al Hennawi, Hussam
    Bedi, Angad
    Khan, Muhammad Khuzzaim
    Zohaib, Muhammad
    Khan, Ibrahim Ahmed
    Mazzoni, Jennifer A.
    CURRENT PROBLEMS IN CARDIOLOGY, 2024, 49 (10)
  • [34] Efficacy and safety of Xa inhibitors in patients with heart failure and coronary or peripheral artery disease: a systematic review and meta-analysis of randomized controlled trials
    Chen, Yuqiao
    Feng, Xiu
    Qi, Chenliang
    Zhou, Lingfeng
    Sun, Yi
    Gu, Zhenhua
    Li, Xiaolong
    ANNALS OF PALLIATIVE MEDICINE, 2021, 10 (07) : 8082 - 8093
  • [35] Sodium-glucose cotransporter-2 Inhibitors in Heart Failure: An Updated Systematic Review and Meta-analysis of 13 Randomized Clinical Trials Including 14,618 Patients With Heart Failure
    Shrestha, Dhan Bahadur
    Budhathoki, Pravash
    Sedhai, Yub Raj
    Karki, Parag
    Gurung, Suja
    Raut, Sumit
    Damonte, Juan Ignacio
    Del, Marco Giuseppe
    Mojadidi, Mohammad Khalid
    Elgendy, Islam Y.
    Patel, Toralben
    Patel, Nimesh K.
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2021, 78 (04) : 501 - 514
  • [36] Sodium glucose co-transporter 2 inhibitors and quality of life in patients with heart failure: a comprehensive systematic review and meta-analysis of randomized controlled trials
    Oriecuia, Chiara
    Tomasoni, Daniela
    Sala, Isabella
    Bonfioli, Giovanni Battista
    Adamo, Marianna
    Gussago, Cristina
    Lombardi, Carlo Mario
    Pagnesi, Matteo
    Savarese, Gianluigi
    Metra, Marco
    Specchia, Claudia
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2024, 10 (02) : 147 - 157
  • [37] Patients With Type 2 Diabetes Mellitus and Heart Failure Benefit More From Sodium-Glucose Cotransporter 2 Inhibitor: A Systematic Review and Meta-Analysis
    Chen, Chengcong
    Peng, Hong
    Li, Mingzhu
    Lu, Xiyan
    Huang, Miao
    Zeng, Yongmei
    Dong, Guoqing
    FRONTIERS IN ENDOCRINOLOGY, 2021, 12
  • [38] Systematic review and meta-analysis of stroke and thromboembolism risk in atrial fibrillation with preserved vs. reduced ejection fraction heart failure
    Zhang, Meijuan
    Zhou, Jie
    BMC CARDIOVASCULAR DISORDERS, 2024, 24 (01):
  • [39] Efficacy and safety of sodium-glucose cotransporter 2 inhibitors initiation in patients with acute heart failure, with and without type 2 diabetes: a systematic review and meta-analysis
    Salah, Husam M.
    Al'Aref, Subhi J.
    Khan, Muhammad Shahzeb
    Al-Hawwas, Malek
    Vallurupalli, Srikanth
    Mehta, Jawahar L.
    Mounsey, J. Paul
    Greene, Stephen J.
    McGuire, Darren K.
    Lopes, Renato D.
    Fudim, Marat
    CARDIOVASCULAR DIABETOLOGY, 2022, 21 (01)
  • [40] Long-term surrogate cardiovascular outcomes of SGLT2 inhibitor empagliflozin in chronic heart failure: a systematic review and meta-analysis
    Yan, Qingkai
    Chen, Xinrao
    Yu, Changqing
    Yin, Yuehui
    BMC CARDIOVASCULAR DISORDERS, 2024, 24 (01):
12345